Mar 4, 2026 05:48AM
Feb 5, 2026 04:15PM
Nov 4, 2025 04:15PM
Sep 30, 2025 06:44AM
May 28, 2025 07:10AM
Feb 28, 2025 12:26PM
Feb 3, 2025 04:15PM Anaptys to Present at the Guggenheim SMID Cap Biotech Conference
Feb 3, 2025 07:30AM
Feb 3, 2025 07:30AM
Dec 12, 2024 07:18AM
Nov 7, 2024 06:13AM
Nov 5, 2024 04:15PM
Oct 21, 2024 06:13AM
Aug 19, 2024 06:14AM Guggenheim Reiterates Buy Rating on AnaptysBio (ANAB)
Aug 14, 2024 06:14AM
Aug 14, 2024 05:00AM
Jan 31, 2024 09:15AM
Nov 1, 2023 09:15AM
Nov 9, 2022 02:10PM
Nov 9, 2022 02:10PM
Nov 1, 2022 06:29AM UPDATE: Guggenheim Upgrades AnaptysBio (ANAB) to Buy
Oct 14, 2020 10:40AM
Oct 14, 2020 09:22AM
Oct 14, 2020 06:21AM
Nov 8, 2019 09:43AM
Feb 22, 2019 07:17AM
Sep 28, 2018 04:05PM
Sep 28, 2018 04:05PM AnaptysBio Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option
Sep 26, 2018 05:53AM
Sep 25, 2018 07:49PM
Sep 25, 2018 07:49PM

22,133 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All